Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Ewing sarcoma is a kind of cancer that grows in bones or soft tissues. The tumor was first described by a pathologist, Dr. James Ewing, in the 1920’s. Most often, it is found in the bones of the pelvis or thigh, though it can arise throughout the body. Ewing sarcoma tends to strike children and young adults between the ages of 5 and 20, and is more common in boys than in girls. Fortunately, treatments for Ewing sarcoma have improved dramatically in recent years, and most children who develop this disease have a good chance for recovery with proper treatment.
Ewing Sarcoma Treatment at Dana-Farber/Boston Children's
Children diagnosed with Ewing Sarcoma are treated at Dana-Farber/Boston Children's through our Bone & Soft Tissue Tumor Program. Our specialists – including pediatric oncologists, surgical oncologists and radiation oncologists – offer a level of expertise in Ewing sarcoma rarely seen at other pediatric cancer centers. We provide the full set of options that can be used to treat Ewing sarcoma, and our specialists can help you determine which option is best for your child.
Find in-depth information on Ewing sarcoma on the Dana-Farber/Boston Children’s website, including answers to:
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”